Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019;15(7-8):1672-1677.
doi: 10.1080/21645515.2018.1558688. Epub 2019 Apr 4.

Adolescent providers' knowledge of human papillomavirus vaccination age guidelines in five countries

Affiliations

Adolescent providers' knowledge of human papillomavirus vaccination age guidelines in five countries

Hillary M Topazian et al. Hum Vaccin Immunother. 2019.

Abstract

Purpose: To examine provider knowledge of HPV vaccination age guidelines in five countries. Methods: A total of 151 providers of adolescent vaccinations in Argentina, Malaysia, South Africa, South Korea, and Spain were interviewed between October 2013 and April 2014. Univariate analyses compared providers' understanding of recommended age groups for HPV vaccination to that of each country's national guidelines. Results: In three of five countries surveyed, most providers (97% South Africa, 95% Argentina, 87% Malaysia) included all nationally recommended ages in their target age group. However, a relatively large proportion of vaccinators in some countries (83% Malaysia, 55% Argentina) believed that HPV vaccination was recommended for women above age 26, far exceeding national guidelines, and beyond the maximum recommended age in the United States. National median minimum and maximum age recommendations cited by the respondents for HPV vaccination were 11 and 29 years in Argentina (national guideline: 11-14), 13 and 48 years in Malaysia (guideline 13-14), 8 and 14 years in South Africa (guideline 9-14), 10 and 20 years in South Korea (guideline 11-14), and 11 and 12 years in Spain (guideline 11-14). In all countries, a higher percentage of vaccinators included all nationally recommended ages for vaccination, as compared to providers who did not administer HPV vaccination. Conclusions: Overall, a substantial proportion of providers incorrectly reported their country's age guidelines for HPV vaccination, particularly the upper age limit. As provider recommendation is among the strongest predictors of successful vaccination uptake among adolescents, improved education and clarification of national guidelines for providers administering HPV vaccination is essential to optimize prevention of infection and associated disease.

Keywords: HPV; Human papillomavirus; adolescent; age guidelines; provider knowledge; vaccination.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Provider-reported age recommendations for HPV vaccination. Horizontal lines represent individual provider responses. Solid vertical lines indicate the lower and upper vaccination age limits from each country's national guidelines, or from international guidelines if no age limits from national guidelines were available. The dashed line indicates an age of 26 years. * No maximum age recommendation indicated
Figure 2.
Figure 2.
Provider knowledge of how many doses of HPV vaccination are needed.

References

    1. 2006 approval letter - human papillomavirus quadrivalent (types 6, 11, 16, 18) vaccine, recombinant. Rockville (MD): Department of Health and Human Services; 2006.
    1. de Martel C, Plummer M, Vignat J, Franceschi S.. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–670. doi:10.1002/ijc.30716. - DOI - PMC - PubMed
    1. Hartwig S, St Guily JL, Dominiak-Felden G, Alemany L, de Sanjosé S. Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe. Infect Agent Cancer. 2017;12(1):19. doi:10.1186/s13027-017-0129-6. - DOI - PMC - PubMed
    1. Castle PE, Fetterman B, Akhtar I, Husain M, Gold MA, Guido R, Glass AG, Kinney W. Age-appropriate use of human papillomavirus vaccines in the U.S. Gynecol Oncol. 2009;114(2):365–369. doi:10.1016/j.ygyno.2009.04.035. - DOI - PMC - PubMed
    1. Hildesheim A, Herrero R. Human papillomavirus vaccine should be given before sexual debut for maximum benefit. J Infect Dis. 2007;196(10):1431–1432. doi:10.1086/522869. - DOI - PubMed

Publication types

Substances